Noile-Immune Biotech Inc. (TYO:4893)
142.00
-3.00 (-2.07%)
Apr 28, 2025, 3:30 PM JST
Noile-Immune Biotech Company Description
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Noile-Immune Biotech Inc.
Country | Japan |
Founded | 2015 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 25 |
CEO | Koji Tamada |
Contact Details
Address: T&G Hamamatsucho Building Minato, 105-0012 Japan | |
Website | noile-immune.com |
Stock Details
Ticker Symbol | 4893 |
Exchange | Tokyo Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | JPY |
ISIN Number | JP3759560000 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Koji Tamada | Chief Executive Officer |
Hiroko Nagai | Chief Financial Officer |
Tsutomu Tokashiki | Chief Operating Officer |